Chicago, Feb. 06, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global contrast media market generated revenue of US$ 5,492.7 million in 2023 and is expected to reach ...

Capacity expansion at Active Pharmaceutical Ingredient facility in Lindesnes, Norway, contributes to GE Healthcare’s aim to produce 30 million more doses of contrast media per year by 2025 This step ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. 53% of patients with an iodinated contrast allergy and ...

Hysterosalpingography (HSG) remains a cornerstone diagnostic and potentially therapeutic procedure in the evaluation of female infertility. The technique involves the injection of contrast media into ...

In 2022, the iodinated contrast media segment held the largest share of the contrast media market, by type segment. Based on type, the global contrast media market is categorized into iodinated ...

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027 i Demand for CT and X-Ray contrast media, ...

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can ...

PHILADELPHIA -- The myth that certain patients need to avoid iodinated contrast media (ICM) for fear of acute kidney injury (AKI) persists despite evidence that there is no additional danger for them, ...

Please provide your email address to receive an email when new articles are posted on . 84.8% of patients who followed the protocol completed CT scans without any adverse reaction. 53.3% of patients ...

Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...